InvestorsHub Logo
Followers 12
Posts 909
Boards Moderated 0
Alias Born 12/30/2004

Re: None

Friday, 10/09/2015 9:33:42 PM

Friday, October 09, 2015 9:33:42 PM

Post# of 55131
Dr Rushton seems like the perfect hire for XXII. He is accomplished and an expert in the field of tobacco genomic research. A perfect fit.

Jonathan Page is an expert in the field of cannabis research, so looks like XXII has the tools in place for advancing research these fields.

Can anyone confirm that Page is still collaborating with XXII? I havent heard his name mentioned recently and Henry's comment about Rushton also spearheading the cannabis end of things had me wondering about Page (as I thought he was the man on that front). Thanks for any clarification.

“Paul’s experience will enable him to contribute immediately to the Company’s Modified Risk Tobacco Products in development and to spearhead our cannabis technology initiatives.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News